Metabolic Effect of Combined Telmisartan and Nifedipine CR Therapy in Patients with Essential Hypertensio
Not Applicable
- Conditions
- Essential Hypertension without metabolic disease
- Registration Number
- JPRN-UMIN000007720
- Lead Sponsor
- Kochi Medical School
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 16
Inclusion Criteria
Not provided
Exclusion Criteria
Patients had diabetes mellitus, hypercholesterolemia, metabolic syndrome or cardiovascular disease and were not taking any anti-hypertensive medicines for at least 6 months.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Metabolic parameters (lipids, glucose, Homa-IR, leptin and aoponectin)
- Secondary Outcome Measures
Name Time Method Blood pressure, heart rate, body weight, and Blood chemistry analysis, neurohormonal parameters (noradrenaline, plasma renin activity, aldosterone)